Use of Bone Resorption Inhibitors in Metastatic Castration-Resistant Prostate Cancer-20 Years Later, and the Answer Is Still Yes

JAMA Netw Open. 2021 Jul 1;4(7):e2117159. doi: 10.1001/jamanetworkopen.2021.17159.
No abstract available

Publication types

  • Comment

MeSH terms

  • Bone Density Conservation Agents* / therapeutic use
  • Humans
  • Male
  • Prostatic Neoplasms, Castration-Resistant* / drug therapy

Substances

  • Bone Density Conservation Agents